1. GaBi Online: Generics and Biosimilars Initiative. Biologicals sales have almost doubled since 2006. Available from: http://www.gabionline.net/Biosimilars/General/Biologicals-sales-have-almost-doubled-since-2006 .
2. PipelineReview.com. Blockbuster biologics 2012. R&D Pipeline News, Special Edition 1/2013. Available from: http://www.pipelinereview.com/index.php/2013050850905/FREE-Reports/Blockbuster-Biologics-2012.html .
3. Windisch J. The science in biosimilars. Emergence of Biosimilar Medicines Symposium, Belgian Federal Parliament, 22 November 2012. Available from: http://www.sympobiosimilars.be/fr/docs/Symposium_Biosimilars_22112012_Presentation_3.pdf
4. Weise M, Bielsky M-C, De Smet K, Ehmann F, Ekman N, Narayanan G, et al. Biosimilars—why terminology matters. Nat Biotechnol. 2012;29(8):690–3.
5. Declerck P, Simoens S. A European perspective on the market accessibility of biosimilars. Biosimilars. 2012;2:33–40.